Precision Scientific announced that it has received in a round of funding led by new investor Shenzhen Salubris Pharmaceuticals Co., Ltd. on June 26, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.26 CNY | +1.13% | +11.13% | -4.29% |
Apr. 23 | Salubris Pharmaceuticals' Q1 Profit Falls 5% Despite 23% Rise in Operating Income | MT |
Apr. 23 | Salubris Pharmaceuticals to Raise Capital of US Unit by $35 Million | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.29% | 4.71B | |
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- 002294 Stock
- News Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Precision Scientific announced that it has received funding from Shenzhen Salubris Pharmaceuticals Co., Ltd.